Zhittya Genesis Medicine Inc.
Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, Multiple sclerosis, and enhance stroke recovery.
New Frontiers in Medicine - Novel Biopharmaceuticals to Potentially Reverse Neurodegenerative Diseases
February 8, 2019, 4:30 pm - 5:15 pm EST